{"id":"W3083036202","doi":"10.1371/journal.pone.0237497","title":"Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria","year":2020,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Apellis Pharmaceuticals; Alexion Pharmaceuticals","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Regimen; Dosing; Pediatrics; Internal medicine; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008792988,0.0001484545,0.0005377117,0.00003260856,0.00009422546,0.000006133048,0.000136028,0.00007138074,0.0001376615],"category_scores_gemma":[0.0001574794,0.0001041586,0.00009587144,0.00006979922,0.0002546837,0.00004470648,0.00007125916,0.00004504553,0.000002072549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002267921,"about_ca_system_score_gemma":0.0001013816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001817022,"about_ca_topic_score_gemma":0.000049928,"domain_scores_codex":[0.9987282,0.0001800229,0.0006322667,0.0002351713,0.00006876241,0.0001555782],"domain_scores_gemma":[0.9984025,0.0006905441,0.0004541184,0.000264425,0.0001437239,0.00004468209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.005842139,0.007359705,0.2714052,0.00229701,0.00640827,3.39032e-7,0.007646181,0.00001342023,0.684689,0.002581846,0.001602955,0.01015388],"study_design_scores_gemma":[0.008781357,0.006535708,0.6279679,0.0002707591,0.001416913,0.000003896203,0.002792628,0.00004595131,0.3498412,0.0007332041,0.001249952,0.0003605259],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988682,0.008112758,0.00005208918,0.0008107577,0.00003805188,0.00102174,0.00120515,0.00001402865,0.00006346263],"genre_scores_gemma":[0.9990833,0.0004182234,0.0001728907,0.00004813481,0.00002149367,0.0001450669,0.000075688,0.00000794579,0.00002722007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3565627,"threshold_uncertainty_score":0.4247464,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1067041951962957,"score_gpt":0.2765882071985561,"score_spread":0.1698840120022604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}